These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36539355)

  • 41. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2012 Jan; 4(1):2-16. PubMed ID: 22287289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Annual banned-substance review: Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2018 Jan; 10(1):9-27. PubMed ID: 29149502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Annual banned-substance review: Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2019 Jan; 11(1):8-26. PubMed ID: 30488582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Applications of liquid chromatography-mass spectrometry in doping control.
    Politi L; Groppi A; Polettini A
    J Anal Toxicol; 2005; 29(1):1-14. PubMed ID: 15808007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M; Schänzer W
    Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2010 Apr; 2(4):149-61. PubMed ID: 20376830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2014; 6(1-2):164-84. PubMed ID: 24285613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.
    Thevis M; Thomas A; Schänzer W
    Anal Bioanal Chem; 2013 Dec; 405(30):9655-67. PubMed ID: 23925796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary Supplements as a Major Cause of Anti-doping Rule Violations.
    Lauritzen F
    Front Sports Act Living; 2022; 4():868228. PubMed ID: 35399596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attitudes and doping: a structural equation analysis of the relationship between athletes' attitudes, sport orientation and doping behaviour.
    Petróczi A
    Subst Abuse Treat Prev Policy; 2007 Nov; 2():34. PubMed ID: 17996097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A conceptual framework for achieving performance enhancing drug compliance in sport.
    Donovan RJ; Egger G; Kapernick V; Mendoza J
    Sports Med; 2002; 32(4):269-84. PubMed ID: 11929355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A third generation approach to detect erythropoietin abuse in athletes.
    Sharpe K; Ashenden MJ; Schumacher YO
    Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge.
    Gild ML; Stuart M; Clifton-Bligh RJ; Kinahan A; Handelsman DJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3562-e3573. PubMed ID: 35438767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls.
    Dib J; Mongongu C; Buisson C; Molina A; Schänzer W; Thuss U; Thevis M
    Drug Test Anal; 2017 Jan; 9(1):61-67. PubMed ID: 27346747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antidoping program: an important factor in the promotion and protection of the integrity of sport and athlete's health.
    Mazzeo F; Monda V; Santamaria S; Nigro E; Valenzano A; Villano I; Cibelli G; Messina A; Messina G
    J Sports Med Phys Fitness; 2018; 58(7-8):1135-1145. PubMed ID: 28738670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. History of mass spectrometry at the Olympic Games.
    Hemmersbach P
    J Mass Spectrom; 2008 Jul; 43(7):839-53. PubMed ID: 18570181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.